Regeneron Pharmaceuticals CEO and Key Executive Team

• Leonard S. Schleifer

  Board Co-Chair, President and Chief Executive Officer, Founder
• George D. Yancopoulos

  Board Co-Chair, President and Chief Scientific Officer, Founder
• Bob McCowan

  Senior Vice President, IT and Chief Information Officer
• Robert E. Landry

  Executive Vice President, Finance and Chief Financial Officer
• Smita Pillai

  Chief Diversity, Equity and Inclusion Officer
• Gonzalo Merino

  Senior Vice President, Chief Intellectual Property Counsel and Associate General Counsel
• Melissa Lozner

  Senior Vice President, Chief Compliance Officer
• Maya Bermingham

  Senior Vice President, Public Policy and Government Affairs
• Joseph J. LaRosa

  Executive Vice President, General Counsel and Secretary
• Daniel Van Plew

  Executive Vice President and General Manager, Industrial Operations and Product Supply
• Marion McCourt

  Executive Vice President, Commercial
• Andrew Murphy

  Executive Vice President, Research
• Neil Stahl

  Executive Vice President, Research and Development
• Sally A. Paull

  Executive Vice President, Human Resources
• Ned Braunstein

  Executive Vice President, Regulatory Affairs and Global Patient Safety
• Leonard Brooks

  Senior Vice President, Treasurer
• Nouhad Husseini

  Senior Vice President, Business Development
• Kerry Reinertsen

  Senior Vice President, Strategic Alliances
• Chris Fenimore

  Senior Vice President, Head of Accounting and Controller
• Hanne Bak

  Senior Vice President, Preclinical Manufacturing and Process Development
• Aris Baras

  Senior Vice President, Regeneron Genetics Center
• Gregory Geba

  Senior Vice President, Global Development Scientific Council
• Gary Herman

  Senior Vice President, Early Clinical Development and Experimental Sciences
• Boaz Hirshberg

  Senior Vice President, Clinical Sciences General Medicine
• Bari Kowal

  Senior Vice President, Development Operations and Portfolio Management
• Johnathan Lancaster

  Senior Vice President, Global Medical Affairs
• John Lin

  Senior Vice President, Immuno-Oncology and Head of Bispecifics
• William Olson

  Senior Vice President, Therapeutic Proteins
• L. Andres Sirulnik

  Senior Vice President, Translational and Clinical Sciences, Hematology
• Randy Soltys

  Senior Vice President, Drug Safety and Pharmacometrics
• Scott Carver

  Senior Vice President, Manufacturing and Process Sciences
• Patrice Gilooly

  Senior Vice President, Quality Assurance and Operations
• Jenny McNay

  Senior Vice President, CMC Regulatory Sciences and Industrial Affairs
• Gerald Underwood

  Senior Vice President, Technical Operations
• Ron Wang

  Senior Vice President, Quality Control
• Niall O’Leary

  Senior Vice President and Site Head, IOPS Raheen
• Gerald Carreau

  Senior Vice President, Commercial Scale Manufacturing and Manufacturing Technology
• Zoran Berkovic

  Senior Vice President, Financial Planning and Analysis
• Richard O'Neal

  Senior Vice President, Market Access
• David Snow

  Senior Vice President, Global Head, Dupixent Franchise
• Mark Volpe

  Senior Vice President, Tax
• Bola Akinlade

  Senior Vice President, Clinical Development, Immunology and Inflammation
• Gang Chen

  Senior Vice President, Protein Expression Sciences
• Christos Kyratsous

  Senior Vice President, Research
• John Calabro

  Senior Vice President, Internal Audit
• Christina Chan

  Senior Vice President, Corporate Affairs
• Matthew Everett

  Senior Vice President, Strategic Sourcing and Procurement
• Alessandra Ravetti

  Senior Vice President, Associate General Counsel
• Thomas Dicioccio

  Senior Vice President, Pharmacometrics
• Benjamin Drosman

  Senior Vice President, Global Development Quality & Regulatory Compliance

Source: regeneron.com, regeneron.com, regeneron.com